Regulation of human D1, D(2(long)), D(2(short)), D3 and D4 dopamine receptors by amiloride and amiloride analogues

British Journal of Pharmacology

Volumn 130, Issue 5, 2000, Pages 1045-1059

  Hoare, S R J ^a   Coldwell, M C ^b   Armstrong, D ^c   Strange, P G ^a,c  

^a UNIVERSITY OF KENT   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF READING   (United Kingdom)

Author keywords

Allosteric regulation; Amiloride; Radioligand binding; Radioligand dissociation

Indexed keywords

AMILORIDE; AMILORIDE DERIVATIVE; BENZAMIL; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); RADIOLIGAND; SULFUR 35;

ALLOSTERISM; ANIMAL CELL; ARTICLE; BINDING COMPETITION; CONCENTRATION (PARAMETERS); DISSOCIATION; DRUG POTENCY; MATHEMATICAL ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033922586     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703370     Document Type: Article

References (33)

1. 4 receptor variants. J. Neurochem., 65, 1157-1165.
2. BIRDSALL, N.J.M., COHEN, F., LAZARENO, S. & MATSUI, H. (1995). Allosteric regulation of G-protein-linked receptors. Biochem. Soc. Trans., 23, 108-111.
3. BIRDSALL, N.J.M., FARRIES, T., GHARAGOZOLOO, P., KOBAYASHI, S., KUONEN, D., LAZARENO, S., POPHAM, A. & SUGIMOTO, M. (1997). Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes. Life Sciences, 60, 1047-1052.
4. BIRDSALL, N.J.M., HULME, E.C., PECK, B.S., STOCKTON, J.M. & ZIGMOND, M. (1986). Two drug binding sites on muscarinic receptors. In New Concepts In Alzheimer's Disease ed. Briley, M., Kato, A. & Weber, M. pp. 102-121. London: MacMillan.
5. 2 dopamine receptor. J. Neurochem., 60, 372-375.
6. CHIDIAC, P. (1998). Rethinking receptor-G-protein-effector interaction. Biochem. Pharmacol., 55, 549-556.
7. ELLIS, J., HUYLER, J. & BRANN, M.R. (1991). Allosteric regulation of cloned M1-M5 muscarinic receptor subtypes. Biochem. Pharmacol., 42, 1927-1932.
8. GRANDY, D.K., MARCHIONNI, M.A., MAKAM, H., STOFKO, R.E., ALFANO, M., FROTHINGHAM, L., FISCHER, J.B., BURKE-HOWIE, K.J., BUNZOW, J.R., SERVER, A.C. & CIVELLI, O. (1989). Cloning of the cDNA and gene for a human D2 dopamine receptor. Proc. Natl. Acad. Sci. U.S.A., 86, 9762-9766.
9. 2b subtypes in a heterologous cell-line. Mol. Endocrinol., 6, 920-926.
10. 2 dopamine receptors by amiloride and amiloride analogues. Mol. Pharmacol., 50, 1295-1308.
11. 2-adrenergic receptors. Mol. Pharmacol., 32, 53-58.
12. KLEYMAN, T.R. & CRAGOE, JR. E.J. (1990). Cation transport probes: the amiloride series. Methods Enzymol., 191, 739-755.
13. KOSHLAND, D.E., NEMETHY, G. & FILMER, D. (1966). Comparison of experimental binding data and theoretical models in proteins containing subunits. Biochemistry, 5, 365-385.
14. LAZARENO, S. & BIRDSALL, N.J.M. (1995). Detection, quantitation and verification of allosteric interactions of agents with labelled and unlabelled ligands at G-protein-coupled receptors - interactions of strychnine and acetylcholine at muscarinic receptors. Mol. Pharmacol., 48, 362-378.
15. 2A adrenergic receptor. Mol. Pharmacol., 53, 916-925.
16. MOOSER, G. & SIGMAN, D.S. (1974). Ligand binding properties of acetylcholinesterase determined with fluorescent probes. Biochemistry, 13, 2299-2307.
17. 2 receptors by sodium and pH. Mol. Pharmacol., 39, 570-578.
18. NEVE, K.A. & NEVE, R.L., eds. (1997). The dopamine receptors, Humana Press, Totowa, New Jersey.
19. PROBST, W.C., SNYDER, L.A., SCHUSTER, D.I , BROSIUS, J. & SEALFON, S.C. (1992). Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol., 11, 1-20.
20. PROSKA, J. & TUCEK, S. (1994). Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine-rcceptors. Mol. Pharmacol., 45, 709-717.
21. SIBLEY, D.R. & MONSMA, F.J. (1992). Molecular biology of dopamine receptors. Trends Pharmacol. Sci., 13, 61-69.
22. SIMMONDS, S.H. & STRANGE, P.G. (1985). Inhibition of inositol phospholipid breakdown by D2 dopamine receptors in dissociated bovine anterior pituitary cells. Neurosci. Letts., 60, 267-272.
23. 3H]histamine in guinea pig cerebral cortex. II. Mechanistic basis for multiple states of affinity. Mol. Pharmacol., 43, 583-594.
24. 3) as a target for neuroleptics. Nature, 347, 146-151.
25. STOCKTON, J.M., BIRDSALL, N.J.M., BURGEN, A.S.V. & HULME, E.C. (1983). Modification of the binding properties of muscarinic receptors by gallamine. Mol. Pharmacol., 23, 551-557.
26. STRADER, C.D., FONG, T.M., GRAZIANO, M.P. & TOTA, M.R. (1995). The family of G-protein-coupled receptors. FASEB J., 9, 745-754.
27. STRANGE, P.G. (1997). Commentary. Neuropsychopharmacology, 16, 116-122.
28. TOMLINSON, G. & HNATOWICH, M.R. (1988). Apparent competitive inhibition of radioligand binding to receptors experimental and theoretical considerations in the analysis of equilibrium binding data. J. Receptor Res., 8, 809-830.
29. TUCEK, S. & PROSKA, J. (1995). Allosteric modulation of muscarinic acetylcholine-rcceptors. Trends Pharmacol. Sci., 16, 205-212.
30. VALLAR, L. & MELDOLESI, J. (1989). Mechanisms of signal transduction at the dopamine D2 receptor. Trends Pharmacol Sci, 10, 74-77.
31. WAELBROECK, M. (1994). Identification of drugs competing with D-tubocurarine for an allosteric site on cardiac muscarinic receptors. Mol. Pharmacol., 46, 685-692.
32. WELLS, J.W. (1992). Analysis and interpretation of binding at equilibrium. In: Receptor-Ligand Interactions. A Practical Approach (Hulme E.C., ed.). Oxford University Press, Oxford, UK, 289-395.
33. ZHOU, Q., GRANDY, D.K., THAMBI, L., KUSHNER, J.A., VAN TOL, H.H.M., CONE, R., PRIBNOW, D., SALON, J., BUNZOW, J.R. & CIVELLI, O. (1990). Cloning and expression of human and rat D1 dopamine receptors. Nature, 347, 76-80.